IXICO is a leading neuroimaging Contract Research Organization (CRO) that specializes in delivering advanced analytics and intelligent insights for clinical trials focused on neurological disorders. The company employs sophisticated artificial intelligence (AI) and machine learning techniques to enhance the analysis of imaging biomarkers, particularly in the context of diseases such as Alzheimer's, Parkinson's, Huntington's Disease, and Multiple Sclerosis. IXICO's capabilities include fully automated detection and quantification of white matter lesions using deep learning, which is essential for monitoring disease progression and evaluating therapeutic efficacy. Their expertise extends to the development and validation of unique neuroimaging methods, as well as the provision of centralized neuroimaging services that support every stage of clinical development, from early-phase trials to post-marketing surveillance.

The company also emphasizes the importance of data management and compliance in clinical trials, utilizing its proprietary TrialTracker platform to streamline complex imaging workflows. This platform ensures secure and compliant data handling, facilitating patient stratification and recruitment through advanced analytics. IXICO's extensive global network of over 2,000 imaging centers across 75 countries allows for rapid site activation and efficient trial execution. By combining their deep neuroscience knowledge with cutting-edge technology and analytics, IXICO aims to reduce clinical development risks and improve the return on investment for their clients in the life sciences industry.

United Kingdom

Advancing medicine and human health by transforming data into clinically meaningful insights.

IXICO is a premier neuroimaging provider helping biopharmaceutical companies maximize the value of their drug development pipelines by transforming data into clinically meaningful insights.

Bringing together world-class therapeutic expertise, breakthrough analytics and operational excellence, IXICO is the proven partner of choice for imaging biomarker solutions in CNS clinical trials.

IXICO

Company Details